News

It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter-million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being.

It has been nearly one year since SARS-COV-2 (COVID-19) changed the world. With millions of people infected and over a quarter-million dead in the United States (U.S.), the novel coronavirus continues its pervasive hold on our health and well-being.

The team will explore potential gait abnormalities, neuromuscular issues and hip joint bone composition in the farming population. Farmers will be referred to this study through the Southeast Center for Agricultural Health and Injury Prevention. 

“We have the expertise and equipment to advance testing procedures and understand more about the virus’ presence in wastewater—gaining knowledge that can help not only our local community, but also areas around the world that may lack testing infrastructure.”

“Although the pandemic changed our plans for an in-person celebration, we are looking forward to spotlighting the initiatives that are moving our mission forward, as well as honoring the individuals who had the vision to establish the center and help lay our foundations.”

Anyone over the age of 18 is invited to complete a short survey from Wellness, Health, & You (WHY), an ongoing research project that seeks to understand how different life experiences affect wellbeing and health.

Wasp dope is a crystalline substance created by electrifying pyrethroid-containing substances – such as wasp sprays – that may give users a methamphetamine-like “rush.” Recent reports have highlighted the emergence of this new drug as an issue of concern, research into the substance is so far lacking.

The National Institutes of Health/National Heart Lung and Blood Institute recently awarded a five-year $3.8 million grant to the University of Kentucky to begin a new study aimed at improving diet and activity among rural Appalachian Kentuckians. 

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

The RUHRC was established in 2016, with an initial HRSA funding award of $2.8 million. Since then, the Center has produced 22 research products, including policy briefs and peer-reviewed publications, as well as more than a dozen related publications.